Inhibition of the PKCγ-ε pathway relieves from meningeal nociception in an animal model: an innovative perspective for migraine therapy? [electronic resource]
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics Apr 2013
- 329-39 p. digital
Publication Type: Journal Article
1878-7479
10.1007/s13311-012-0151-8 doi
Animals Blotting, Western Cold Temperature Cyclic AMP Response Element-Binding Protein--metabolism Hot Temperature Interleukin-1beta--metabolism Male Meninges--physiopathology Mice Migraine Disorders--drug therapy Motor Activity--drug effects NF-kappa B--metabolism Nitric Oxide Donors--metabolism Nitric Oxide Synthase Type II--metabolism Nociception--drug effects Pain--drug therapy Pain Measurement Pain Threshold--drug effects Protein Kinase C--antagonists & inhibitors Protein Kinase C-epsilon--antagonists & inhibitors Protein Kinase Inhibitors--therapeutic use Psychomotor Performance--drug effects STAT1 Transcription Factor--metabolism